Association of Relative Cerebral Blood Volume from Dynamic Susceptibility Contrast-Enhanced Perfusion MR with HER2 Status in Breast Cancer Brain Metastases
- 21 December 2022
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 30 (9) , 1816-1822
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Crosstalk between HER2 signaling and angiogenesis in breast cancerCurrent Opinion in Oncology, 2013
- Perfusion MRI: The Five Most Frequently Asked Technical QuestionsAmerican Journal of Roentgenology, 2013
- Advances in MRI Assessment of Gliomas and Response to Anti-VEGF TherapyCurrent Neurology and Neuroscience Reports, 2011
- Receptor conversion in distant breast cancer metastasesBreast Cancer Research, 2010
- HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancerAnnals of Oncology, 2009
- Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain TumorsRadiology, 2008
- Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up StudyAmerican Journal of Neuroradiology, 2008
- The role of HER2 in angiogenesisSeminars in Oncology, 2001
- Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR ImagingRadiology, 1999
- Perfusion imaging with NMR contrast agentsMagnetic Resonance in Medicine, 1990